Chang David D
Allogene Therapeutics, Inc. · President and CEO
Chang David D is listed in public filings as director, officer: President and CEO. This Chang David D insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Allogene Therapeutics, Inc. (ALLO). Investors use Chang David D's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $13M5.2M shares | SellMar 16, 2026 | $118.0K47.8k shares | $2.47 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.6M1.4M shares | Grant / ExerciseFeb 2, 2026 | $2.6M1.4M shares | $1.87 | -- | |
| --392.6k shares | Grant / ExerciseFeb 2, 2026 | Disclosure amount unavailable392.6k shares | -- | -- | |
| $9.3M5.2M shares | SellFeb 2, 2026 | $171.5K95.3k shares | $1.80 | -- | |
| $10M5.3M shares | SellMar 14, 2025 | $91.5K46.7k shares | $1.96 | -- | |
| $8.9M5.3M shares | SellFeb 3, 2025 | $77.3K46k shares | $1.68 | -- | |
| $3.8M2M shares | Grant / ExerciseJan 24, 2025 | $3.8M2M shares | $1.94 | -- | |
| --5.4M shares | Grant / ExerciseJan 24, 2025 | Disclosure amount unavailable552.2k shares | -- | -- |